ePosters
Spinal neurostimulators are used to treat refractory chronic neuropathic pain. However, the durability of these devices has been challenged as prior research has demonstrated explant rates up to 30%. Given upfront costs associated with device implant, it is crucial to identify factors that may predict device explant. The goals of this study were to identify spinal neurostimulator device explant rates at various time intervals and identify patient factors associated with higher explant rates.
Gabriella H. Wozniak, D.O.
Resident Physician
University of Rochester Department of Physicial Medicine and Rehabilitation
Rochester, New York, United States
Hemant Kalia, M.D., M.P.H.
President and Chief Medical Officer
C.R.I.S.P Center for Research and Innovation in Spine & Pain, United States
Ramzi El-Hassan, M.D., M.S.
Assistant Professor
URMC Department of Physical Medicine & Rehabilitation, United States
Andrew Stephens, M.D.
Interventional Spine & Musculoskeletal Medicine Fellow
Stanford University Department of Physicial Medicine And Rehabiliation, United States